TP53 and cancer: Recent evidence suggests that although mutations in the p53 tumor suppressor gene are recognized as “driver” mutations in cancer [1], additional tumor-promoting events, such as cooperation with other oncogenic pathways, are emerging as essential mechanisms of cancer progression [2].